Galectin-3 as a Predictor of Left Ventricular Reverse Remodeling in Recent-Onset Dilated Cardiomyopathy.

Konstantinos KaratoliosGeorgios ChatzisVolker HolzendorfStefan StörkAnette RichterDavis BinasBernhard SchiefferSabine Pankuweit

Published in: Disease markers (2018)

Our study suggests that baseline galectin-3 is an independent predictor of LVRR. Low levels of galectin-3 may be regarded a useful biomarker of favorable ventricular remodeling in patients with RODCM.

Keyphrases

left ventricular
heart failure
acute myocardial infarction
hypertrophic cardiomyopathy
mitral valve
atrial fibrillation